Feng Chi Biotech Corp. (6744) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Feng Chi Biotech Corp. (6744:TWSE), powered by AI.

Current Price
$15.90
Sector
Healthcare
What is the Feng Chi Biotech Corp. stock price forecast?

Feng Chi Biotech Corp. is currently trading at $15.90. View real-time AI analysis on Alpha Lenz.

What is Feng Chi Biotech Corp. insider trading activity?

View the latest insider trading data for Feng Chi Biotech Corp. on Alpha Lenz.

What is Feng Chi Biotech Corp.'s P/E ratio?

View Feng Chi Biotech Corp.'s valuation metrics on Alpha Lenz.

Feng Chi Biotech Corp.

TWSE · 6744
NT$15.90+0.00(+0.00%)
Ask about Feng Chi Biotech Corp.'s future dividend policy...
Alpha Chat Insight

Feng Chi Biotech Corp.'s ROE is 6.0%. Explore profitability and growth together.

Ask for details

Company Overview

Feng Chi Biotech Corp. is a biotechnology company headquartered in Taipei, Taiwan, specializing in *genetic testing* and life science services. The firm offers a range of medical diagnostic solutions, including preimplantation genetic testing, prenatal genetic screening, newborn screening for heritable conditions, food and pharmaceutical microbiological testing, and medical translational research. It is also active in the distribution of advanced genetic testing technologies, particularly in the field of oncology, supporting precision medicine initiatives in areas such as colorectal and lung cancer. With a core focus on health technology, the company serves both healthcare providers and scientific researchers, playing a key role in public health, clinical diagnostics, and biomedical research sectors. Founded in 1992, Feng Chi Biotech Corp. supports healthcare innovation by delivering reliable diagnostic tools, thereby impacting disease prevention, early detection, and personalized treatment strategies in Taiwan’s growing healthcare market.

SectorHealthcare
IndustryBiotechnology
Employees32

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$177.36MRevenue
0.00Shares Out
32Employees

Margins

44.63%Gross
16.48%EBITDA
7.81%Operating
9.55%Pre-Tax
8.16%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-2.85%Rev 3Yr
-0.17%Rev 5Yr
-20.02%Op Inc 3Yr
-13.49%Op Inc 5Yr
-16.22%Net Inc 3Yr
-10.63%Net Inc 5Yr

Returns

4.93%ROA
6.03%ROE
5.83%ROIC

Financial Health

NT$17.39MCash & Cash Equivalents
NT$30.62MNet Debt
20.01%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Feng Chi Biotech Corp. (ticker: 6744) is a company listed on TWSE in the Healthcare sector (Biotechnology). It has approximately 32 employees.

The current price is 15.9 with a P/E ratio of -x and P/B of -x.

ROE is 6.03% and operating margin is 7.81%. Annual revenue is $177M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Feng Chi Biotech Corp. (6744) Stock Forecast 2026 $15.90 — Price, Financials & Analyst Targets | Alpha Lenz